Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | February 29, 2012 | March 02, 2012 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | November 19, 2021 | November 23, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date February 29, 2012 · Filed March 02, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 144,311 |
Ending reported balance
After 2012-03-01 transaction · row 24
24 source rows · reconciled sequenceRow 1 · 2012-02-29 · Sale · Disposed 4,900 · Balance 220,896 Row 2 · 2012-02-29 · Sale · Disposed 5,750 · Balance 215,146 Row 3 · 2012-02-29 · Sale · Disposed 700 · Balance 214,446 Row 4 · 2012-02-29 · Sale · Disposed 4,115 · Balance 210,331 Row 5 · 2012-02-29 · Sale · Disposed 200 · Balance 210,131 Row 6 · 2012-02-29 · Sale · Disposed 15,135 · Balance 194,996 Row 7 · 2012-02-29 · Sale · Disposed 12,318 · Balance 182,678 Row 8 · 2012-02-29 · Sale · Disposed 2,800 · Balance 179,878 Row 9 · 2012-02-29 · Sale · Disposed 2,300 · Balance 177,578 Row 10 · 2012-02-29 · Sale · Disposed 4,403 · Balance 173,175 Row 11 · 2012-02-29 · Sale · Disposed 200 · Balance 172,975 Row 12 · 2012-02-29 · Sale · Disposed 3,697 · Balance 169,278 Row 13 · 2012-02-29 · Sale · Disposed 2,200 · Balance 167,078 Row 14 · 2012-02-29 · Sale · Disposed 100 · Balance 166,978 Row 15 · 2012-02-29 · Sale · Disposed 1,560 · Balance 165,418 Row 16 · 2012-02-29 · Sale · Disposed 100 · Balance 165,318 Row 17 · 2012-02-29 · Sale · Disposed 100 · Balance 165,218 Row 18 · 2012-02-29 · Sale · Disposed 4,300 · Balance 160,918 Row 19 · 2012-02-29 · Sale · Disposed 700 · Balance 160,218 Row 20 · 2012-02-29 · Sale · Disposed 907 · Balance 159,311 Row 21 · 2012-03-01 · Sale · Disposed 3,737 · Balance 155,574 Row 22 · 2012-03-01 · Sale · Disposed 7,000 · Balance 148,574 Row 23 · 2012-03-01 · Sale · Disposed 100 · Balance 148,474 Row 24 · 2012-03-01 · Sale · Disposed 4,163 · Balance 144,311 |
| Common shares without par valueSEC Table I · non-derivative | IndirectProfit Sharing Trust | 6,660 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 25
Holding and transaction disclosures are not merged.
1 source rowRow 25 · Balance 6,660 F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy wife | 20,400 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 26
Holding and transaction disclosures are not merged.
1 source rowRow 26 · Balance 20,400 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 27
Holding and transaction disclosures are not merged.
1 source rowRow 27 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
| Common shares without par valueSEC Table I · non-derivative | IndirectBy daughter | 250 |
Reported balance
Holding disclosure · report date 2012-02-29 · row 28
Holding and transaction disclosures are not merged.
1 source rowRow 28 · Balance 250 F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. |
Filing footnotes · ownership attribution and instrument terms
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 28, 2012.
F2: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date November 19, 2021 · Filed November 23, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 26,123 |
Reported balance
After 2021-11-19 transaction · row 1
1 source rowRow 1 · 2021-11-19 · Grant · Acquired 4,271 · Balance 26,123 F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs") granted on November 19, 2021, which vest in full one year from the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,403 | $56.82 | $250,178.46 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 10 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,175 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,300 | $56.81 | $130,663.00 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,578 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $56.81 | $159,054.00 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 179,878 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 12,318 | $56.80 | $699,662.40 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,678 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 15,135 | $56.80 | $859,592.33 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,996 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $56.79 | $11,358.50 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,131 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,115 | $56.79 | $233,690.85 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,331 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 700 | $56.79 | $39,749.50 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,446 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,750 | $56.78 | $326,485.00 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,146 Read SEC document |
| February 29, 2012 Filed Mar 2, 2012 22:16 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,900 | $56.78 | $278,197.50 |
DisclosureSEC source: 0001179110-12-004066 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,896 Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption(right to buy) · Derivative | 44,000 | $0.00 Strike: $56.26 | $0.00 |
DisclosureSEC source: 0001179110-12-003242 · edgar.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,000 Underlying: Common shares · 44,000 shares Expires 2022-02-16 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 14,667 on 02/17/2013, 14,666 on 02/17/2014, and 14,667 on 02/17/2015. Read SEC document |
| February 17, 2012 Filed Feb 22, 2012 23:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 24,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-12-003242 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,696 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| December 16, 2011 Filed Dec 30, 2011 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-017306 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 250 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. Read SEC document |
| December 16, 2011 Filed Dec 30, 2011 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-017306 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By daughter Disclosed balance after: 250 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. Read SEC document |
| December 16, 2011 Filed Dec 30, 2011 22:06 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-017306 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,296 Read SEC document |
| December 15, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 1,918 | $0.00 Strike: $52.12 | $0.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · derivative · entry 30 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 1,918 shares Expires 2012-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 15, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,843 | $54.23 | $99,945.89 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 23 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,496 Read SEC document |
| December 15, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 1,918 | $52.12 | $99,968.85 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 22 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,339 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 69,163 | $0.00 Strike: $53.63 | $0.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · derivative · entry 29 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 69,163 shares Expires 2012-02-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 8,722 | $0.00 Strike: $52.12 | $0.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · derivative · entry 28 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 8,722 shares Expires 2012-01-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.36 | $5,435.50 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 21 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,421 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.35 | $10,870.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 20 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,521 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $54.35 | $5,434.50 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 19 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,721 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $54.34 | $43,472.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 18 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,821 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $54.34 | $10,867.80 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 17 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,621 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,800 | $54.34 | $260,808.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 16 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,821 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,119 | $54.33 | $115,125.27 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 15 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,621 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,327 | $54.32 | $398,002.64 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 14 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,740 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,100 | $54.32 | $168,388.90 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 13 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,067 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $54.32 | $27,158.75 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 12 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,167 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 17,900 | $54.32 | $972,238.50 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 11 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,667 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 5,173 | $54.31 | $280,945.63 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 10 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,567 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 800 | $54.30 | $43,440.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 9 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,740 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,900 | $54.30 | $266,045.50 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 8 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,540 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 19,866 | $54.29 | $1,078,525.14 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 7 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,440 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $54.29 | $16,286.70 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,306 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $54.29 | $54,287.50 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 5 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,606 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 7,000 | $54.29 | $379,995.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 4 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,606 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,700 | $54.28 | $92,276.00 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,606 Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 69,163 | $53.63 | $3,708,865.88 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,306 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2011 Filed Dec 16, 2011 22:18 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 8,722 | $52.12 | $454,602.85 |
DisclosureSEC source: 0001179110-11-016802 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2011 Filed Oct 28, 2011 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GiftCommon shares without par value | 100 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-014543 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,421 Read SEC document |
| May 12, 2011 Filed Oct 28, 2011 21:12 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | OtherCommon shares without par value | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-014543 · edgar.xml · nonDerivative · entry 3 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By wife Disclosed balance after: 20,400 F2 · balance_after: The reporting person disclaims beneficial ownership of all securities held by his wife and daughters. Read SEC document |
| May 01, 2011 Filed May 3, 2011 21:27 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 1,452 | $52.04 | $75,562.08 |
DisclosureSEC source: 0001179110-11-007248 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,521 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,564 | $47.91 | $74,935.93 |
DisclosureSEC source: 0001179110-11-003911 · edgar.xml · nonDerivative · entry 2 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,973 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 22:07 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,161 | $47.64 | $436,430.04 |
DisclosureSEC source: 0001179110-11-003911 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,537 Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 35,600 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003274 · edgar.xml · derivative · entry 6 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,600 Underlying: Common shares · 35,600 shares Expires 2021-02-17 F4 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 11,867 on 02/18/2012, 11,866 on 02/18/2013, and 11,867 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:55 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 25,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003274 · edgar.xml · nonDerivative · entry 1 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,698 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionOption (right to buy) · Derivative | 53,202 | $0.00 Strike: $45.45 | $0.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · derivative · entry 16 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 53,202 shares Expires 2011-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| February 08, 2011 Filed Feb 10, 2011 21:57 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,300 | $45.50 | $104,650.00 |
DisclosureSEC source: 0001179110-11-002406 · edgar.xml · nonDerivative · entry 11 Hance Robert B · CIK 0001383841 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,398 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.